CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
Studying the relationship between plasma levels of CXCL13 and systemic immune activation during the early phases of infection and during ART
View PublicationStudying the relationship between plasma levels of CXCL13 and systemic immune activation during the early phases of infection and during ART
View PublicationAssessing the effectiveness of human papillomavirus (HPV) vaccination in women with and without human immunodeficiency virus (HIV)
View PublicationStudying HIV transmissions dynamics among men who have sex with men
View PublicationAssessing how patient characteristics and hepatitis C coinfection affect treatment amongst people living with HIV
View PublicationStudying the retention of antiretroviral therapy in Zomba district, Malawi, after the introduction of Universal Test and Treatment
View PublicationStudying the birth rates of women living with HIV compared to the general population in BC
View PublicationEstimating the impact of HIV-related stigma on brain health and everyday functioning among 512 older white men living with HIV in Canada
View PublicationMarion Di Ciaccio, Luis Sagaon-Teyssier, Christel Protière, Mohamed Mimi, Marie Suzan-Monti, Laurence Meyer, Daniela Rojas CastroGilles PialouxClaire PintadoJean Michel MolinaMarie PréauBruno Spire
View PublicationStudy assessing feasibility of further research relating to oral cannabinoid consumption and inflamation amongst people living with HIV
View PublicationStudying social ecological pathways affecting quality of life, with a focus on economic insecurity and social support, among women living with HIV
View Publication